Facephi Consults ICAC on Revenue Recognition Related to R&D
Facephi Biometria has submitted a technical consultation to the Institute of Accounting and Audit (ICAC) regarding the accounting treatment of certain transactions. This initiative specifically addresses operations involving Economic Interest Groupings (EIG) and the recognition of revenues linked to tax financing structures for research and development activities.
The technical consultation was addressed to the ICAC in connection with the Market Notice on the Audited Annual Accounts for the fiscal year 2025, published on May 4, 2026. This step aims to clarify the accounting treatment applicable to certain transactions involving Economic Interest Groupings and the recognition of revenues associated with tax financing structures for the company's research and development activities.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Related
SectorLogiciels et Services Informatiques›Logiciels
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 2025
Key reported figures
Revenue: 36 M€
EBITDA: 10,5 M€
Net income: 0.4M€
Free cash flow: -2,4 M€
Risks mentioned
Baisse des bénéfices de -€8,9M en 2024.
Opportunities identified
Croissance du chiffre d'affaires de 24,6 %.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
